Session » Healthcare Disparities in Rheumatology Poster

Date: Saturday, November 12, 2022

Time: 1:00PM-3:00PM

Meeting: ACR Convergence 2022

1:00PM-3:00PM: Abstract Number: 0106

A Systematic Review of Racial and Ethnic Disparities in Disease Related Outcomes Among Patients with SLE

1:00PM-3:00PM: Abstract Number: 0114

Addressing Healthcare Disparities Through Implementation of a Medical Student-Based Patient Navigator Program

1:00PM-3:00PM: Abstract Number: 0091

Association of Area-Level Heat and Social Vulnerability with Recurrent Hospitalizations Among Individuals with Rheumatic Conditions

1:00PM-3:00PM: Abstract Number: 0095

Association of Urban vs. Rural Residence with New DMARD Initiation in US Veterans with Active Rheumatoid Arthritis

1:00PM-3:00PM: Abstract Number: 0094

Black Patients Are Less Satisfied with the Hospital Experience After Primary Hip and Knee Arthroplasty

1:00PM-3:00PM: Abstract Number: 0088

Challenges in the Management of Psoriatic Arthritis in Latin America: A Systematic Review

1:00PM-3:00PM: Abstract Number: 0092

Characterizing Levels of Specialist Care Received by Patients with Systemic Lupus Erythematosus: Clinical Characteristics, Emergency Care, Hospitalization, and Costs Among Commercially-insured Adults in the United States

1:00PM-3:00PM: Abstract Number: 0085

Closing the Gender Gap in Global Rheumatology Leadership- Are We There Yet?

1:00PM-3:00PM: Abstract Number: 0093

Comparison of Faculty and Fellow Prescribing Patterns for Rheumatoid Arthritis in an Urban, Academic Hospital

1:00PM-3:00PM: Abstract Number: 0100

COVID Vaccinations in Patients with Rheumatologic Diseases- perspectives and Disparities in a Safety-net Tertiary Care Hospital in Memphis, Tennessee

1:00PM-3:00PM: Abstract Number: 0096

Delayed Referral of Female Rheumatoid Arthritis Patients: Where Are We Now? A Study Spanning Three Decades

1:00PM-3:00PM: Abstract Number: 0098

Delays in Access to Specialized Care and Diagnosis in Patients with Systemic Lupus Erythematosus

1:00PM-3:00PM: Abstract Number: 0117

Disparities in Prescription Medications Among Myositis Patients in a Large Urban Medical Center

1:00PM-3:00PM: Abstract Number: 0122

Documentation of Social Determinants of Health Among Individuals with Systemic Rheumatic and Musculoskeletal Diseases

1:00PM-3:00PM: Abstract Number: 0110

Does Access Reduce Excess Use? Lupus Outcomes in Two Distinct Socioeconomic Groups Seen by University Rheumatologists

1:00PM-3:00PM: Abstract Number: 0087

Does Limited English Proficiency Lead to Additional Health Inequity in Medically Vulnerable Populations in Outpatient Rheumatology?

1:00PM-3:00PM: Abstract Number: 0119

Emergency Department Utilization by Persons with Inflammatory Arthritis Conditions Varies by Geographic Location of Residence

1:00PM-3:00PM: Abstract Number: 0120

Epstein Barr Virus Reactivation in Native American Rheumatic Disease Patients Is Associated with Systemic Disease and Rheumatoid Arthritis but Not Other Rheumatic Diseases

1:00PM-3:00PM: Abstract Number: 0113

Escalation to Biologics After Methotrexate Among US Veterans with Rheumatoid Arthritis Living in Rural versus Urban Areas

1:00PM-3:00PM: Abstract Number: 0115

Facilitators of Immunosuppressive Medication Adherence in Systemic Lupus Erythematosus: A Qualitative Study of Racial Minority Patients, Lupus Providers and Clinic Staff

1:00PM-3:00PM: Abstract Number: 0111

Gender Equity in the Asia Pacific: Comparison of Indian and Philippines Rheumatology Conferences

1:00PM-3:00PM: Abstract Number: 0104

Gender Representation of the Editors and Editorial Boards of the Top 45 Rheumatology-Focused Journals

1:00PM-3:00PM: Abstract Number: 0099

Impact of Multimodal Independent Medical Education on Improving Outcomes and Reducing Disparities in Systemic Lupus Erythematosus and Lupus Nephritis

1:00PM-3:00PM: Abstract Number: 0102

Impact of Racial Implicit Bias on Juvenile Idiopathic Arthritis Patients’ Treatment Recommendations

1:00PM-3:00PM: Abstract Number: 0090

Lack of Racial and Ethnic Diversity in Clinical Trials of Psoriatic Arthritis

1:00PM-3:00PM: Abstract Number: 0086

Patient and Provider Perspectives on Barriers to Communication and Care of Latinx Patients with Lupus and Rheumatoid Arthritis

1:00PM-3:00PM: Abstract Number: 0116

Racial Differences in Medication Beliefs and Barriers to Taking Medications Among Patients with SLE

1:00PM-3:00PM: Abstract Number: 0089

Racial Disparities in Rheumatology Clinical Trials

1:00PM-3:00PM: Abstract Number: 0103

Retention in Rheumatology Care and Receipt of Lupus-Specific Serologic Testing Among Young Adults with Systemic Lupus Erythematosus: A Medicare Cohort Study

1:00PM-3:00PM: Abstract Number: 0121

Rheumatoid Arthritis Care Experiences of Black People Living in Canada: A Qualitative Study to Inform Treatment Guidelines

1:00PM-3:00PM: Abstract Number: 0097

Sex and Race/ethnicity Differences in Knee Symptoms, Function, and Radiographic Features: Preliminary Descriptive Data from the Johnston County Health Study

1:00PM-3:00PM: Abstract Number: 0118

Sex-Based Variations in Emergency Department Utilization by Persons with Inflammatory Arthritis Conditions

1:00PM-3:00PM: Abstract Number: 0107

Short-, Intermediate- and Long-Term Renal Outcomes in Hispanics from Puerto Rico with Lupus Nephritis: Induction Therapy with Cyclophosphamide vs. Mycophenolate Mofetil

1:00PM-3:00PM: Abstract Number: 0108

Study of the Level of Antibody Response to COVID-19 Vaccine in a Minority Population with Rheumatological Disorders

1:00PM-3:00PM: Abstract Number: 0105

Supplemental Primary Dose of the COVID-19 Vaccine in Immunosuppressed Patients on DMARDs and Biologic Agents

1:00PM-3:00PM: Abstract Number: 0109

The Impact of Marginalization on Health Outcomes in Childhood-onset Systemic Lupus Erythematosus

1:00PM-3:00PM: Abstract Number: 0101

Twenty-five Years of Mortality Data in Those with Lower Extremity Osteoarthritis: The Role of Socioeconomic Status

1:00PM-3:00PM: Abstract Number: 0112

What Drives Racial Disparities in Gout in the USA? – Population-Based, Sex-Specific, Casual Mediation Analysis

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].